Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin vs Docetaxel in Metastatic BRCA-Mutated Breast Cancer
NCT00321633Phase 2Completed
- Sponsor
- UCLH
- Start
- Sep 2005
- Primary completion
- Sep 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 6
01
Overview
A Phase 2 trial of carboplatin in breast cancer, sponsored by UCLH. Started Sep 2005; status: completed.
02
Drugs
carboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00321633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00321633.